Ilico Genetics

Did you know stomach cancer kills more than 750,000 people worldwide each year? Most are diagnosed too late. But it doesn’t have to be this way.

Detecting cancer at its earliest stages means more treatment options, less invasive care, and significantly lower costs. At Ilico Genetics, our work is focused on changing the timeline, catching cancer years earlier than current methods.

Because the earlier it’s found, the more lives we can save.

Every global idea starts somewhere. Ilico Genetics began as a spin-off from the Pontificia Universidad Católica de Chile, where pioneering research into gastric cancer laid the foundation for what would become a life-changing innovation.

Today, we’re proud to call Bethlehem, Pennsylvania, home, a city with a rich history of industry and innovation.

From Latin America to the United States, our journey reflects a single truth: cancer has no borders, and neither should the solutions.

We’re building a bridge between research and real-world healthcare– bringing the best of science to patients everywhere.

Stomach cancer isn’t just about lifestyle or environment; genetics can play a powerful role in determining your risk. Certain inherited mutations, such as those in the CDH1 or MLH1 genes, can increase susceptibility, often without visible early symptoms.

Here at Ilico Genetics, we believe that knowledge is prevention. Genetic testing can help identify at-risk individuals, so you can take action before cancer has the chance to develop.

Early detection means more options, better outcomes, and peace of mind for you and your family.

✅ Know your risk. Protect your future.
💬 Talk to your doctor about screenings for stomach cancer.